Article Details

Initial Clinical Data from Editas Medicine's BRILLIANCE Clinical Trial of EDIT-101 for LCA10 ...

Retrieved on: 2021-09-07 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Initial Clinical Data from Editas Medicine's BRILLIANCE Clinical Trial of EDIT-101 for LCA10 .... View article details on hiswai:

Excerpt

07, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing ... Casey Eye Institute, Oregon Health & Science University.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up